# Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect

> **NCT02071121** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 39 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BIIB061
- **DRUG:** Placebo
- **DRUG:** 14C-BIIB061

## Key facts

- **NCT ID:** NCT02071121
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2015-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02071121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02071121, "Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02071121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*